Aim: We explored demoralisation syndrome among post-operative patients with breast cancer and its relationship with patients' body image and marital intimacy.

Design: A cross-sectional study.

Methods: In this cross-sectional study, 237 patients with breast cancer who were hospitalised in the breast surgery department of Grade A tertiary hospital in Xiamen, China from June 2022 to December 2023 and met the standards of adaxation were selected by the convenience sampling method. The survey tool consists of four parts: general data questionnaire, demoralisation scale-II (DS-II), quality of relationship index (QRI) and body image scale (BIS).

Results: In this study, we examined the demoralisation syndrome in 237 post-operative breast cancer patients, predominantly aged 45-59 years (47.3%), with the majority living with family (94.1%) and having children (95.4%). A small proportion (5.9%) lived alone, and 3% were uninsured, opting to pay for their treatment out-of-pocket. The majority (83.1%) had undergone mastectomy, and 51.9% visited the hospital for chemotherapy, with 5.1% experiencing disease recurrence. The mean demoralisation score was 8.52 (SD = 8.47). We found that 22.8% had moderate and 14.8% had severe demoralisation symptoms. Socioeconomic factors such as age, residence, income, tumour staging, post-operative time, hospital purpose and disease recurrence were associated with demoralisation. Multivariate analysis revealed that income, cancer stage, recurrence, quality of recovery index (QRI) and BIS were independent influencing factors for demoralisation syndrome after breast cancer surgery. These findings highlight the importance of considering a range of patient characteristics when addressing demoralisation in post-operative breast cancer patients.

Patient Contribution: Demoralisation syndrome in patients after breast cancer surgery is influenced by a combination of sociodemographics, disease, intimate relationship and body image. Clinical medical staff should accurately evaluate and identify patients with demoralisation syndrome after breast cancer surgery and formulate and implement personalised intervention strategies according to their physical conditions and possible influencing factors, so as to reduce the incidence of demoralisation syndrome and improve the quality of life.

Download full-text PDF

Source
http://dx.doi.org/10.1002/nop2.70130DOI Listing

Publication Analysis

Top Keywords

breast cancer
32
demoralisation syndrome
28
patients breast
16
demoralisation
12
body image
12
cancer surgery
12
breast
9
cancer
9
syndrome post-operative
8
post-operative patients
8

Similar Publications

Ultrasound-responsive nanoparticles for nitric oxide release to inhibit the growth of breast cancer.

Cancer Cell Int

December 2024

Department of Ultrasound, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.

Gas therapy represents a promising strategy for cancer treatment, with nitric oxide (NO) therapy showing particular potential in tumor therapy. However, ensuring sufficient production of NO remains a significant challenge. Leveraging ultrasound-responsive nanoparticles to promote the release of NO is an emerging way to solve this challenge.

View Article and Find Full Text PDF

Targeting CDK2 to circumvent treatment resistance in HR breast cancer.

Trends Mol Med

December 2024

Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address:

Genetic and epigenetic defects of the p53 system have previously been associated with resistance to CDK4/6 inhibitors in women with HR breast cancer. Recent data from Kudo et al. demonstrate that CDK2-targeting agents may offer an effective strategy to circumvent such resistance by enforcing cellular senescence downstream of RBL2 dephosphorylation.

View Article and Find Full Text PDF

Dabrafenib upregulates hypoglycosylated MUC1 and improves the therapeutic efficacy of Tn-MUC1 CAR-T cells.

Sci Bull (Beijing)

December 2024

Breast Cancer Center, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China. Electronic address:

View Article and Find Full Text PDF

Computational Pathology Detection of Hypoxia-Induced Morphological Changes in Breast Cancer.

Am J Pathol

December 2024

Department of Computer Science, Faculty of Engineering Sciences, University College London, Gower Street, London, WC1E 6BT, United Kingdom.

Understanding the tumor hypoxic microenvironment is crucial for grasping tumor biology, clinical progression, and treatment responses. This study presents a novel application of AI in computational histopathology to evaluate hypoxia in breast cancer. Weakly Supervised Deep Learning (WSDL) models can accurately detect morphological changes associated with hypoxia in routine Hematoxylin and Eosin (H&E) whole slide images (WSI).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!